U.S. flag

An official website of the United States government

Talk to the Veterans Crisis Line now
Skip to main content

Retired innovation

This innovation is no longer being updated.

Pharmacogenomics testing for Veterans (PHASER)

Last updated

Share Print

Our goal is to optimize the use of nearly 40 medicines by adjusting prescriptions to a Veterans genetic profile. Using a blood sample, Veterans are tested for 11 different genes that affect medications for mental health, pain, cardiovascular, & inflammatory conditions. Alerts are placed in the medical record to warn a provider during prescribing of a drug-gene interaction & to recommend changes.


March 2019, Durham VA Medical Center


13 successful, 9 in-progress

Awards and Recognition:

FedHealth IT Award


Diffusion tracker

Does not include Clinical Resource Hubs (CRH)


There are no unsuccessful adoptions for this innovation.




Deepak Voora, MD (Director, PHASER program) discusses the pharmacogenomic testing offered through the PHASER program with one of his patients and the first Veteran to be tested under the program. PHASER testing is typically offered by providers during a patient encounter. Results are returned to patients by the PHASER program and stored in the medical record for future use.